Research Article
Increased Brain Iron Deposition in the Putamen in Patients with Type 2 Diabetes Mellitus Detected by Quantitative Susceptibility Mapping
Table 1
Clinical characteristics of the participants.
| | T2DM () | HC () | Statistical value ( or ) | |
| Gender (male) | 14 (43.75%) | 20 (62.50%) | 2.259 | 0.133 | Age (years) | | | -0.809 | 0.421 | Risk factors for cardiovascular disease | | | | | BMI (kg/m2) | | | 1.315 | 0.104 | Fasting serum cholesterol (mmol/l) | | | 0.398 | 0.634 | Fasting serum triglycerides (mmol/l) | | | 1. 324 | 0.117 | Hypertension | 15 (46.88%) | 13 (40.62%) | 0.254 | 0.614 | Use of antihypertensive medication | 12 (37.50%) | 11 (37.50%) | 0.068 | 0.794 | History of myocardial infarction | 0 | 0 | | | SVD scores | | | 1.291 | 0.208 | Type 2 diabetes-related factors | | | | | Fasting plasma glucose (mmol/l) | | | 3.551 | <0.001 | HbA1c (mmol/mol) | | — | | | HbA1c (%) | | — | | | Diabetes duration (years) | | — | | | Use of insulin | 16 (50.00%) | — | | | Type 2 diabetes microvascular complications | | | | | Retinopathy | 7 (21.87%) | — | | | Chronic kidney disease | 2 (6.25%) | — | | | Peripheral somatic neuropathy | 8 (25.00%) | — | | | Autonomic cardiovascular neuropathy | 5 (15.62%) | — | | |
|
|
a: Chi-square test; b: independent samples -test; c: Mann–Whitney test. |